Literature DB >> 20506560

Deletions of SCN1A 5' genomic region with promoter activity in Dravet syndrome.

Tojo Nakayama1, Ikuo Ogiwara, Koichi Ito, Makoto Kaneda, Emi Mazaki, Hitoshi Osaka, Hideyuki Ohtani, Yushi Inoue, Tateki Fujiwara, Mitsugu Uematsu, Kazuhiro Haginoya, Shigeru Tsuchiya, Kazuhiro Yamakawa.   

Abstract

Mutations involving the voltage-gated sodium channel alpha(I) gene SCN1A are major genetic causes of childhood epileptic disorders, as typified by Dravet syndrome. Here we investigated the upstream regions of the SCN1A 5' noncoding exons and found two major regions with promoter activity. These two major promoters were simultaneously active in various brain regions and in most neurons. Using multiplex ligation-dependent probe amplification (MLPA) assays with probes for the 5' noncoding exons, their upstream regions, and all coding exons of SCN1A, we investigated 130 epileptic patients who did not show any SCN1A mutations by sequence analysis of all coding exons and exon-intron boundaries. Among 71 Dravet syndrome patients, we found two patients with heterozygous microdeletions removing the 5' noncoding exons and regions with promoter activity but not affecting the coding exons. We also identified four patients with deletions/duplication in the coding region. One patient with symptomatic focal epilepsy also showed a deletion in the coding region. This study provides the first case of microdeletion limited to the SCN1A 5' promoter region with the coding sequence preserved, and indicates the critical involvement of this upstream region in the molecular pathology of Dravet syndrome. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20506560     DOI: 10.1002/humu.21275

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  14 in total

Review 1.  RNA Structures as Mediators of Neurological Diseases and as Drug Targets.

Authors:  Viachaslau Bernat; Matthew D Disney
Journal:  Neuron       Date:  2015-07-01       Impact factor: 17.173

2.  A Point Mutation in SCN1A 5' Genomic Region Decreases the Promoter Activity and Is Associated with Mild Epilepsy and Seizure Aggravation Induced by Antiepileptic Drug.

Authors:  Qu-Wen Gao; Li-Dong Hua; Jie Wang; Cui-Xia Fan; Wei-Yi Deng; Bin Li; Wen-Jun Bian; Chuan-Xing Shao; Na He; Peng Zhou; Wei-Ping Liao; Yi-Wu Shi
Journal:  Mol Neurobiol       Date:  2016-03-11       Impact factor: 5.590

3.  Aberrant Inclusion of a Poison Exon Causes Dravet Syndrome and Related SCN1A-Associated Genetic Epilepsies.

Authors:  Gemma L Carvill; Krysta L Engel; Aishwarya Ramamurthy; J Nicholas Cochran; Jolien Roovers; Hannah Stamberger; Nicholas Lim; Amy L Schneider; Georgie Hollingsworth; Dylan H Holder; Brigid M Regan; James Lawlor; Lieven Lagae; Berten Ceulemans; E Martina Bebin; John Nguyen; Gregory S Barsh; Sarah Weckhuysen; Miriam Meisler; Samuel F Berkovic; Peter De Jonghe; Ingrid E Scheffer; Richard M Myers; Gregory M Cooper; Heather C Mefford
Journal:  Am J Hum Genet       Date:  2018-12-06       Impact factor: 11.025

Review 4.  Non-coding regulatory elements: Potential roles in disease and the case of epilepsy.

Authors:  Susanna Pagni; James D Mills; Adam Frankish; Jonathan M Mudge; Sanjay M Sisodiya
Journal:  Neuropathol Appl Neurobiol       Date:  2021-12-16       Impact factor: 6.250

5.  Transcription of the human sodium channel SCN1A gene is repressed by a scaffolding protein RACK1.

Authors:  Zhao-Fei Dong; Ling-Jia Tang; Guang-Fei Deng; Tao Zeng; Shu-Jing Liu; Rui-Ping Wan; Ting Liu; Qi-Hua Zhao; Yong-Hong Yi; Wei-Ping Liao; Yue-Sheng Long
Journal:  Mol Neurobiol       Date:  2014-01-17       Impact factor: 5.590

6.  A novel variant in the 3' UTR of human SCN1A gene from a patient with Dravet syndrome decreases mRNA stability mediated by GAPDH's binding.

Authors:  Tao Zeng; Zhao-Fei Dong; Shu-Jing Liu; Rui-Ping Wan; Ling-Jia Tang; Ting Liu; Qi-Hua Zhao; Yi-Wu Shi; Yong-Hong Yi; Wei-Ping Liao; Yue-Sheng Long
Journal:  Hum Genet       Date:  2014-01-25       Impact factor: 4.132

7.  dCas9-Based Scn1a Gene Activation Restores Inhibitory Interneuron Excitability and Attenuates Seizures in Dravet Syndrome Mice.

Authors:  Gaia Colasante; Gabriele Lignani; Simone Brusco; Claudia Di Berardino; Jenna Carpenter; Serena Giannelli; Nicholas Valassina; Simone Bido; Raffaele Ricci; Valerio Castoldi; Silvia Marenna; Timothy Church; Luca Massimino; Giuseppe Morabito; Fabio Benfenati; Stephanie Schorge; Letizia Leocani; Dimitri M Kullmann; Vania Broccoli
Journal:  Mol Ther       Date:  2019-09-03       Impact factor: 11.454

8.  Parallel functional testing identifies enhancers active in early postnatal mouse brain.

Authors:  Jason T Lambert; Linda Su-Feher; Karol Cichewicz; Tracy L Warren; Iva Zdilar; Yurong Wang; Kenneth J Lim; Jessica L Haigh; Sarah J Morse; Cesar P Canales; Tyler W Stradleigh; Erika Castillo Palacios; Viktoria Haghani; Spencer D Moss; Hannah Parolini; Diana Quintero; Diwash Shrestha; Daniel Vogt; Leah C Byrne; Alex S Nord
Journal:  Elife       Date:  2021-10-04       Impact factor: 8.140

9.  A human Dravet syndrome model from patient induced pluripotent stem cells.

Authors:  Norimichi Higurashi; Taku Uchida; Christoph Lossin; Yoshio Misumi; Yohei Okada; Wado Akamatsu; Yoichi Imaizumi; Bo Zhang; Kazuki Nabeshima; Masayuki X Mori; Shutaro Katsurabayashi; Yukiyoshi Shirasaka; Hideyuki Okano; Shinichi Hirose
Journal:  Mol Brain       Date:  2013-05-02       Impact factor: 4.041

10.  Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A.

Authors:  Dalia Kasperaviciute; Claudia B Catarino; Mar Matarin; Costin Leu; Jan Novy; Anna Tostevin; Bárbara Leal; Ellen V S Hessel; Kerstin Hallmann; Michael S Hildebrand; Hans-Henrik M Dahl; Mina Ryten; Daniah Trabzuni; Adaikalavan Ramasamy; Saud Alhusaini; Colin P Doherty; Thomas Dorn; Jörg Hansen; Günter Krämer; Bernhard J Steinhoff; Dominik Zumsteg; Susan Duncan; Reetta K Kälviäinen; Kai J Eriksson; Anne-Mari Kantanen; Massimo Pandolfo; Ursula Gruber-Sedlmayr; Kurt Schlachter; Eva M Reinthaler; Elisabeth Stogmann; Fritz Zimprich; Emilie Théâtre; Colin Smith; Terence J O'Brien; K Meng Tan; Slave Petrovski; Angela Robbiano; Roberta Paravidino; Federico Zara; Pasquale Striano; Michael R Sperling; Russell J Buono; Hakon Hakonarson; João Chaves; Paulo P Costa; Berta M Silva; António M da Silva; Pierre N E de Graan; Bobby P C Koeleman; Albert Becker; Susanne Schoch; Marec von Lehe; Philipp S Reif; Felix Rosenow; Felicitas Becker; Yvonne Weber; Holger Lerche; Karl Rössler; Michael Buchfelder; Hajo M Hamer; Katja Kobow; Roland Coras; Ingmar Blumcke; Ingrid E Scheffer; Samuel F Berkovic; Michael E Weale; Norman Delanty; Chantal Depondt; Gianpiero L Cavalleri; Wolfram S Kunz; Sanjay M Sisodiya
Journal:  Brain       Date:  2013-09-06       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.